16093865Jensen DM, Marcellin PEuropean journal of gastroenterology & hepatologyAntiviral Agents; Hepatitis C, Chronic; Interferon-alpha; Polyethylene Glycols; RibavirinAdult; Aged; Drug Therapy, Combination; Female; Hepacivirus; Humans; Interferon alpha-2; Male; Middle Aged; Recombinant Proteins; Research Design; RNA, Viral; Sample Size; Treatment Failure; Treatment OutcomeRationale and design of the REPEAT study: a phase III, randomized, clinical trial of peginterferon alfa-2a (40 kDa) plus ribavirin in non-responders to peginterferon alfa-2b (12 kDa) plus ribavirin. Eur J Gastroenterol Hepatol. 2005 Sep; 17(9):899-904.Eur J Gastroenterol Hepatol2005-09-01T00:00:002005Rationale and design of the REPEAT study: a phase III, randomized, clinical trial of peginterferon alfa-2a (40 kDa) plus ribavirin in non-responders to peginterferon alfa-2b (12 kDa) plus ribavirin.Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD012367Chemicals & Drugs221480.947936RNA, ViralD000368Living Beings46094410.373134AgedD016898Chemicals & Drugs27660.954034Interferon-alphaD016896Concepts & Ideas36434750.519213Treatment OutcomeD011092Chemicals & Drugs22550.948951Polyethylene GlycolsD018401Concepts & Ideas19250.990242Sample SizeD000998Chemicals & Drugs351310.880623Antiviral AgentsD011994Chemicals & Drugs762510.939523Recombinant Proteins4ProfessorD008875Concepts & IdeasLiving Beings48398170.373681Middle AgedD019698Disorders12780.899297Hepatitis C, ChronicD017211Concepts & Ideas831590.942613Treatment FailureD000328Living Beings51685930.393483AdultD008297Physiology564156270.299065MaleD012254Chemicals & Drugs5320.970269RibavirinD005260Physiology579162020.293532FemaleRush University, Rush Medical Collegetrue1ProfessorProfessorInternal Medicine, Division of Digestive Diseases and NutritionDonaldJensenDonald M. Jensen349747Jensen, DonaldProfessorAuthorship 2206210.2760340.2760341authors10.2519has subject areaD006801Living Beings643293340.211949HumansD016174Living Beings9730.934123HepacivirusD004359Procedures902410.940339Drug Therapy, CombinationD012107Concepts & IdeasLiving BeingsProcedures1172120.86681Research Design